Preferential expression of PAPPA in human preadipocytes from omental fat.
Fat distribution differs between individuals, and those with visceral fat predominance develop metabolic profiles that increase the risk of adverse cardiovascular events. This is due, in part, to the proinflammatory state associated with visceral obesity as well as depot-specific adipogenesis. The IGF system is important in adipose tissue development and metabolic function. Pregnancy-associated plasma protein A (PAPPA) is a novel zinc metalloproteinase that regulates local IGF availability. The first aim of this study was to characterize PAPPA mRNA and protein expression in primary cultures of human preadipocytes isolated from omental, mesenteric, and subcutaneous depots. PAPPA expression was significantly increased in omental preadipocytes compared with mesenteric and subcutaneous preadipocytes. The second aim of this study was to investigate the factors regulating PAPPA expression, focusing on proinflammatory cytokines and resveratrol that have been shown to have negative and positive effects, respectively, on metabolism and diet-induced obesity. Treatment of cultured primary human preadipocytes with tumor necrosis factor α and interleukin 1β led to significant increases in PAPPA expression. Activated pathways mediating cytokine-induced PAPPA expression include the nuclear factor κB pathway and the MAPK family, particularly c-Jun NH2-terminal kinase and p38 MAPK. Resveratrol, a polyphenolic compound with beneficial cardiometabolic effects, significantly downregulated PAPPA expression under basal and stimulated conditions. Effects of resveratrol on PAPPA appeared to be mediated through pathways independent of silent mating type information regulation 2 homolog 1 (SIRT1) and AMP kinase activation. Depot-specific PAPPA expression in human preadipocytes may contribute to a depot-specific function.
Endocrine Research UnitDivision of EndocrinologyKogod Center on AgingMayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Caroline
C
Davidge-Pitts
Endocrine Research UnitDivision of EndocrinologyKogod Center on AgingMayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Carlos J
CJ
Escande
Endocrine Research UnitDivision of EndocrinologyKogod Center on AgingMayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA Conover.Cheryl@mayo.edu.
Cheryl A
CA
Conover
D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D017667:Adipocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000328:Adult; D002478:Cells, Cultured; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D053583:Interleukin-1beta / Q000494:pharmacology; D050152:Intra-Abdominal Fat / Q000166:cytology / Q000378:metabolism*; D008297:Male; D008643:Mesentery / Q000166:cytology / Q000378:metabolism*; D009852:Omentum / Q000166:cytology / Q000378:metabolism*; D011266:Pregnancy-Associated Plasma Protein-A / Q000096:biosynthesis* / Q000235:genetics; D000077185:Resveratrol; D015398:Signal Transduction / Q000187:drug effects; D056564:Sirtuin 1 / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D013267:Stilbenes / Q000494:pharmacology; D050151:Subcutaneous Fat / Q000166:cytology / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D053583:Interleukin-1beta; D013267:Stilbenes; D014409:Tumor Necrosis Factor-alpha; D055372:AMP-Activated Protein Kinases; D011266:Pregnancy-Associated Plasma Protein-A; C447939:SIRT1 protein, human; D056564:Sirtuin 1; D000077185:Resveratrol
PAPPA; adipose tissue; cytokines; inflammation; resveratrol